Lymphocytic Hypophysitis Presenting as Acute-onset Arginine Vasopressin Deficiency and Pituitary Stalk Thickening
A Case Report
DOI:
https://doi.org/10.15605/jafes.040.01.08Keywords:
lymphocytic hypophysitis, arginine vasopressin deficiency, pituitary stalk, infundibulumAbstract
Lymphocytic hypophysitis (LHy) is a rare autoimmune inflammatory process that selectively affects the neurohypophysis and infundibulum, typically presenting with arginine vasopressin deficiency (AVP-D). On magnetic resonance imaging (MRI) with contrast, there is a thickening of the pituitary stalk, enlargement of the neurohypophysis or both with homogeneous enhancement. LHy can be self-limiting and regression can be seen radiologically during follow-up.
A 22-year-old male presented with clinical findings consistent with AVP-D in 2016. MRI brain demonstrated enlargement of the pituitary stalk and absence of a posterior pituitary bright spot. He was given a trial of glucocorticoid treatment. His serial MRI brain showed a reduction of the pituitary stalk, but the AVP-D persisted. He was diagnosed with LHy.
LHy is characterized by lymphocytic infiltration, leading to eventual destruction of the pituitary tissue accompanied by varying degrees of pituitary dysfunction. Definite diagnosis can only be established via pituitary stalk biopsy. Due to the wide range of possible aetiologies, close monitoring is strongly recommended for the treatment of presumed cases lacking histopathologic confirmation. The response rate to glucocorticoids has been variable. Periodic monitoring of anterior pituitary function and pituitary MRI are essential in the management of this condition.
Downloads
References
1. Langlois F et al. Hypophysitis, the growing spectrum of a rare pituitary disease. J Clin Endocrinol Metab. 2022;107(1):10-28. https://pubmed.ncbi.nlm.nih.gov/34528683 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684465 https://doi.org/10.1210/clinem/dgab672
2. Faje A. Hypophysitis: Evaluation and management. Clin Diabetes Endocrinol. 2016;2:15. https://pubmed.ncbi.nlm.nih.gov/28702249 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471685 https://doi.org/10.1186/s40842-016-0034-8
3. Gubbi S, Hannah-shmouni F, Verbalis JG, Koch CA. Hypophysitis: An update on the novel forms, diagnosis and management of disorders of pituitary inflammation. Best Pract Res Clin Endocrinol Metab. 2019;33(6):101371. https://pubmed.ncbi.nlm.nih.gov/31866206 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078033 https://doi.org/10.1016/j.beem.2019.101371
4. Rivera JA. Lymphocytic hypophysitis: Disease spectrum and approach to diagnosis and therapy. Pituitary. 2006;9(1):35-45. https://pubmed.ncbi.nlm.nih.gov/16703407 https://doi.org/10.1007/s11102-006-6598-z
5. Turcu AF, Erckson BJ, Lin E, et al. Pituitary stalk lesions: The Mayo Clinic experience. J Clin Endocrinol Metab. 2013;98(5):1812-8. https://pubmed.ncbi.nlm.nih.gov/23533231 https://doi.org/10.1210/jc.2012-4171
6. Arihara Z, Sakurai K, Niitsuma S, et al. Studies on anti-rabphilin-3A antibodies in 15 consecutive patients presenting with central diabetes insipidus at a single referral center. Sci Rep. 2022;12(1):4440. https://pubmed.ncbi.nlm.nih.gov/35292721 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924241 https://doi.org/10.1038/s41598-022-08552-y
7. Iwama S, Sugimura Y, Kiyota A, et al. Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab. 2015;100(7):E946-54. https://pubmed.ncbi.nlm.nih.gov/25919460 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393526 https://doi.org/10.1210/jc.2014-4209
8. Hasebe M, Shibue K, Honjo S, Hamasaki A. A case of lymphocytic infundibulo-neurohypophysitis exhibiting spontaneous regression. JCEM Case Rep. 2023;1(2):luad020. https://pubmed.ncbi.nlm.nih.gov/37908468 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580413 https://doi.org/10.1210/jcemcr/luad020
9. Inaba H, Susuki S, Shigematsu S, et al. Lymphocytic infundibuloneurohypophysitis: Long-term follow-up of a case cured with glucocorticoid. Med Princ Pract. 2010;19(1):79-81. https://pubmed.ncbi.nlm.nih.gov/19996626 https://doi.org/10.1159/000252841
10. Krishnappa B, Shah R, Memon SS, et al. Glucocorticoid therapy as first-line treatment in primary hypophysitis: A systematic review and individual patient data meta-analysis. Endocr Connect. 2022;12(2):e220311. https://pubmed.ncbi.nlm.nih.gov/36445257 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874965 https://doi.org/10.1530/EC-22-0311
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Zi Yang Lian, Shanty Velaiutham
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The full license text is available at: http://creativecommons.org/licenses/by-nc/3.0/legalcode.
To request permission to translate, reproduce, download, or use articles or images for commercial reuse or business purposes from the Journal of the ASEAN Federation of Endocrine Societies (JAFES), kindly complete the Permission Request for Use of Copyrighted Material Form and email jafes@asia.com or jafes.editor@gmail.com.
A written agreement will be issued to the requester once permission has been granted.
